Low patient accrual rates cause termination of over 25 per cent rare disease trials: GlobalData Read more
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase III trial Read more
Scientists at IIT Madras identify energy deficiency in brain cells as major cause for Parkinson’s Disease Read more